Cridanimod sodium
Based on 1 publication(s) in Google Scholar
Cridanimod sodium is an antiviral agent that induces interferon production in mice. Cridanimod can be utilized in antiviral research.
For research use only. We do not sell to patients.
- CAS No.: 58880-43-6
- Formula: C15H10NNaO3
- Molecular Weight:275.23
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-105055
Didemnin BDepsipeptide -
HY-106019
LiarozoleRAMBA -
HY-16950
4-HydroxytamoxifenEstrogen Receptor Modulator -
HY-118065
FenhexamidAntifungal Agent -
HY-N3940
Gelsevirine -
HY-123805
KIN1400IRF3 Activator -
HY-134495
N-Acetyl-L-cysteine ethyl esterAntioxidant -
HY-128749A
D-Glucaric acid tetrahydrateEndogenous Metabolite -
HY-B0652
EtonogestrelProgesterone/ERR Agonist -
HY-114988
PGE-MProstaglandin E2 Metabolite -
HY-113254
13,14-Dihydro-15-keto-PGE25-HT Modulator -
HY-34386
6(5H)-PhenanthridinonePARP-1 Inhibitor
Publications Citing Use of MedChemExpress (MCE) Cridanimod sodium
More
Biological Activity
Description
Chemical Information
-
CAS No. 58880-43-6
-
Molecular Weight 275.23
-
Formula C15H10NNaO3
-
SMILES
O=C(CN1C2=C(C(C3=C1C=CC=C3)=O)C=CC=C2)O[Na]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
J Ethnopharmacol
2023 Jul 15:311:116427. PMID: 37001770
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Cridanimod sodium Related Classifications
HY-W011890A Related Classifications
Powered by Bioz